{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:41:26Z","timestamp":1792791686356,"version":"4.5.0"},"reference-count":40,"publisher":"Massachusetts Medical Society","issue":"25","license":[{"start":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T00:00:00Z","timestamp":1529539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"name":"Krebsforschung Schweiz\/Swiss Cancer Research","id":[{"id":"https:\/\/ror.org\/022wnsy59","id-type":"ROR","asserted-by":"crossref"}]},{"name":"La Ligue Contre Le Cancer, France","id":[{"id":"https:\/\/ror.org\/00rkrv905","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Children\u2019s Cancer Research Trust, New Zealand"},{"DOI":"10.13039\/100000738","name":"The Department of Veterans Affairs","doi-asserted-by":"crossref","award":["Veterans Administration Merit Review Grant"],"award-info":[{"award-number":["Veterans Administration Merit Review Grant"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007155","name":"The Walter S. and Lucienne Driscill Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C8346\/A8156"],"award-info":[{"award-number":["C8346\/A8156"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"NIH Clinical Center","doi-asserted-by":"publisher","award":["2R13-CA086959"],"award-info":[{"award-number":["2R13-CA086959"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"NIH Clinical Center","doi-asserted-by":"publisher","award":["R01-CA137488"],"award-info":[{"award-number":["R01-CA137488"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"NIH Clinical Center","doi-asserted-by":"publisher","award":["R01-CA199111"],"award-info":[{"award-number":["R01-CA199111"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2018,6,21]]},"DOI":"10.1056\/nejmoa1801109","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T17:01:53Z","timestamp":1529514113000},"page":"2376-2385","source":"Crossref","is-referenced-by-count":370,"title":["Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss"],"prefix":"10.1056","volume":"378","author":[{"given":"Penelope R.","family":"Brock","sequence":"first","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Maibach","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Childs","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaukab","family":"Rajput","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Roebuck","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Laithier","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind","family":"Ronghe","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Dall\u2019Igna","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiso","family":"Hiyama","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Brichard","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Skeen","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Elena","family":"Mateos","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Capra","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun A.","family":"Rangaswami","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ansari","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Rechnitzer","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth J.","family":"Veal","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Covezzoli","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Brugi\u00e8res","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Perilongo","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Czauderna","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Morland","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Neuwelt","sequence":"additional","affiliation":[{"name":"From Great Ormond Street Hospital, London (P.R.B., K.R., D.R.), Nottingham Clinical Trials Unit, Nottingham (M. Childs), Royal Hospital for Sick Children, Glasgow (M.R.), Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne (G.J.V.), and University of Birmingham, Birmingham (B.M.) \u2014 all in the United Kingdom; International Breast Cancer Study Group, Bern (R.M.), and H\u00f4pital Universitaire de Gen\u00e8ve, Geneva (M.A.) \u2014 both in Switzerland; University of Melbourne, Melbourne,..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/hpb.12112"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-006-0361-5"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(00)00074-5"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.12.011"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810613"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.00.5355"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1044\/jslhr.4304.902"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-0178"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.3109\/05384917009071991"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950190415"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.69.2319"},{"key":"e_1_3_5_13_2","first-page":"362","article-title":"Cisplatin ototoxicity in children with hepatoblastoma: can it be reduced? Results from the SIOPEL strategy group.","volume":"47","author":"Brock PR","year":"2006","unstructured":"Brock PR, Brugieres L, Perilongo G, et al. Cisplatin ototoxicity in children with hepatoblastoma: can it be reduced? Results from the SIOPEL strategy group. Pediatr Blood Cancer 2006;47:362-362. abstract.","journal-title":"Pediatr Blood Cancer"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-97-6-845"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1985.3.2.237"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/81.20.1552"},{"key":"e_1_3_5_17_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-3565(24)37559-7","article-title":"First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate.","volume":"286","author":"Neuwelt EA","year":"1998","unstructured":"Neuwelt EA, Brummett RE, Doolittle ND, et al. First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate. J Pharmacol Exp Ther 1998;286:77-84.9655844","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200211000-00016"},{"key":"e_1_3_5_19_2","first-page":"309","article-title":"Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity.","volume":"6","author":"Muldoon LL","year":"2000","unstructured":"Muldoon LL, Pagel MA, Kroll RA, et al. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity. Clin Cancer Res 2000;6:309-315.10656463","journal-title":"Clin Cancer Res"},{"key":"e_1_3_5_20_2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0022-3565(24)38819-6","article-title":"Rescue from enhanced alkylator-induced cell death with low molecular weight sulfur-containing chemoprotectants.","volume":"296","author":"Muldoon LL","year":"2001","unstructured":"Muldoon LL, Walker-Rosenfeld SL, Hale C, Purcell SE, Bennett LC, Neuwelt EA. Rescue from enhanced alkylator-induced cell death with low molecular weight sulfur-containing chemoprotectants. J Pharmacol Exp Ther 2001;296:797-805.11181909","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_5_21_2","first-page":"493","article-title":"Delayed sodium thiosulfate as an otoprotectant against carboplatin-induced hearing loss in patients with malignant brain tumors.","volume":"7","author":"Doolittle ND","year":"2001","unstructured":"Doolittle ND, Muldoon LL, Brummett RE, et al. Delayed sodium thiosulfate as an otoprotectant against carboplatin-induced hearing loss in patients with malignant brain tumors. Clin Cancer Res 2001;7:493-500.11297239","journal-title":"Clin Cancer Res"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.063347"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apha.2014.06.002"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2289"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280100319"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.1110"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)83372-4"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfw070"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.10376"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.02.004"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0097"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2011.10.005"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.2307\/2530245"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70272-9"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30625-8"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30630-1"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20529"},{"key":"e_1_3_5_38_2","first-page":"S36","article-title":"Cisplatin therapy in infants: short and long-term morbidity.","volume":"18","author":"Brock PR","year":"1992","unstructured":"Brock PR, Yeomans EC, Bellman SC, Pritchard J. Cisplatin therapy in infants: short and long-term morbidity. Br J Cancer Suppl 1992;18:S36-S40.1323992","journal-title":"Br J Cancer Suppl"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21919"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-007-0545-1"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01837-1"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa1801109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T03:02:36Z","timestamp":1751684556000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa1801109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,21]]},"references-count":40,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2018,6,21]]}},"alternative-id":["10.1056\/NEJMoa1801109"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa1801109","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,21]]}}}